Teva Pharma (NYSE: TEVA) AdCom for reslizumab is "not going super smooth thus far," according to Evecore ISI's Umer Raffat ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE